Article Text
Therapeutics
Irbesartan was renoprotective in patients with type 2 diabetes, hypertension, and microalbuminuria
Statistics from Altmetric.com
Footnotes
↵† Information provided by author.
-
Sources of funding: Sanofi-Synthelabo and Bristol-Myers Squibb.
-
For correspondence: Dr H Parving, Steno Diabetes Center, Gentofte, Denmark. hhp{at}novo.dk.